The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Metabolic Biomarker Testing-Global Market Insights and Sales Trends 2024
Synopsis
In medicine, a biomarker is a measurable indicator of the severity or presence of some disease state. More generally a biomarker is anything that can be used as an indicator of a particular disease state or some other physiological state of an organism.
The global Metabolic Biomarker Testing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Metabolic Biomarker Testing in various end use industries. The expanding demands from the Drug Discovery, Nutrigenomics, Toxicology Testing and Personalized Medicine, are propelling Metabolic Biomarker Testing market. Separation Techniques, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Detection Techniques segment is estimated at % CAGR for the next seven-year period.
Biomarkers are useful in a number of ways, including measuring the progress of disease, evaluating the most effective therapeutic regimes for a particular cancer type, and establishing long-term susceptibility to cancer or its recurrence. The parameter can be chemical, physical or biological. Biomarkers help in early diagnosis, disease prevention, drug target identification, drug response etc. Several biomarkers have been identified for many diseases such as serum LDL for cholesterol, blood pressure, and P53 gene[4]and MMPs [5] as tumor markers for cancer. Biomarkers are also seen as the key to personalised medicine, treatments individually tailored to specific patients for highly efficient intervention in disease processes. Often, such biomarkers indicate changes in metabolic processes.
Report Objectives
This report provides market insight on the different segments, by players, by Technology, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Metabolic Biomarker Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Metabolic Biomarker Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Metabolic Biomarker Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Metabolic Biomarker Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Metabolic Biomarker Testing covered in this report include Agilent Technologies, Bio-Rad Laboratories, Bruker, Danaher, Waters Corporation, Thermo Fisher Scientific, Biocrates Life Sciences and Human Metabolome Technologies, etc.
The global Metabolic Biomarker Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Agilent Technologies
Bio-Rad Laboratories
Bruker
Danaher
Waters Corporation
Thermo Fisher Scientific
Biocrates Life Sciences
Human Metabolome Technologies
Global Metabolic Biomarker Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Metabolic Biomarker Testing market, Segment by Technology:
Separation Techniques
Detection Techniques
Others
Global Metabolic Biomarker Testing market, by Application
Drug Discovery
Nutrigenomics
Toxicology Testing
Personalized Medicine
Functional Genomics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Technology, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Metabolic Biomarker Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
In medicine, a biomarker is a measurable indicator of the severity or presence of some disease state. More generally a biomarker is anything that can be used as an indicator of a particular disease state or some other physiological state of an organism.
The global Metabolic Biomarker Testing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Metabolic Biomarker Testing in various end use industries. The expanding demands from the Drug Discovery, Nutrigenomics, Toxicology Testing and Personalized Medicine, are propelling Metabolic Biomarker Testing market. Separation Techniques, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Detection Techniques segment is estimated at % CAGR for the next seven-year period.
Biomarkers are useful in a number of ways, including measuring the progress of disease, evaluating the most effective therapeutic regimes for a particular cancer type, and establishing long-term susceptibility to cancer or its recurrence. The parameter can be chemical, physical or biological. Biomarkers help in early diagnosis, disease prevention, drug target identification, drug response etc. Several biomarkers have been identified for many diseases such as serum LDL for cholesterol, blood pressure, and P53 gene[4]and MMPs [5] as tumor markers for cancer. Biomarkers are also seen as the key to personalised medicine, treatments individually tailored to specific patients for highly efficient intervention in disease processes. Often, such biomarkers indicate changes in metabolic processes.
Report Objectives
This report provides market insight on the different segments, by players, by Technology, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Metabolic Biomarker Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Metabolic Biomarker Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Metabolic Biomarker Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Metabolic Biomarker Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Metabolic Biomarker Testing covered in this report include Agilent Technologies, Bio-Rad Laboratories, Bruker, Danaher, Waters Corporation, Thermo Fisher Scientific, Biocrates Life Sciences and Human Metabolome Technologies, etc.
The global Metabolic Biomarker Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Agilent Technologies
Bio-Rad Laboratories
Bruker
Danaher
Waters Corporation
Thermo Fisher Scientific
Biocrates Life Sciences
Human Metabolome Technologies
Global Metabolic Biomarker Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Metabolic Biomarker Testing market, Segment by Technology:
Separation Techniques
Detection Techniques
Others
Global Metabolic Biomarker Testing market, by Application
Drug Discovery
Nutrigenomics
Toxicology Testing
Personalized Medicine
Functional Genomics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Technology, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Metabolic Biomarker Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Metabolic Biomarker Testing
1.1 Metabolic Biomarker Testing Market Overview
1.1.1 Metabolic Biomarker Testing Product Scope
1.1.2 Metabolic Biomarker Testing Market Status and Outlook
1.2 Global Metabolic Biomarker Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Metabolic Biomarker Testing Market Size by Region (2018-2029)
1.4 Global Metabolic Biomarker Testing Historic Market Size by Region (2018-2023)
1.5 Global Metabolic Biomarker Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Metabolic Biomarker Testing Market Size (2018-2029)
1.6.1 North America Metabolic Biomarker Testing Market Size (2018-2029)
1.6.2 Europe Metabolic Biomarker Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Metabolic Biomarker Testing Market Size (2018-2029)
1.6.4 Latin America Metabolic Biomarker Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Metabolic Biomarker Testing Market Size (2018-2029)
2 Metabolic Biomarker Testing Market by Technology
2.1 Introduction
2.1.1 Separation Techniques
2.1.2 Detection Techniques
2.1.3 Others
2.2 Global Metabolic Biomarker Testing Market Size by Technology: 2018 VS 2022 VS 2029
2.2.1 Global Metabolic Biomarker Testing Historic Market Size by Technology (2018-2023)
2.2.2 Global Metabolic Biomarker Testing Forecasted Market Size by Technology (2024-2029)
2.3 Key Regions Market Size by Technology
2.3.1 North America Metabolic Biomarker Testing Revenue Breakdown by Technology (2018-2029)
2.3.2 Europe Metabolic Biomarker Testing Revenue Breakdown by Technology (2018-2029)
2.3.3 Asia-Pacific Metabolic Biomarker Testing Revenue Breakdown by Technology (2018-2029)
2.3.4 Latin America Metabolic Biomarker Testing Revenue Breakdown by Technology (2018-2029)
2.3.5 Middle East and Africa Metabolic Biomarker Testing Revenue Breakdown by Technology (2018-2029)
3 Metabolic Biomarker Testing Market Overview by Application
3.1 Introduction
3.1.1 Drug Discovery
3.1.2 Nutrigenomics
3.1.3 Toxicology Testing
3.1.4 Personalized Medicine
3.1.5 Functional Genomics
3.1.6 Others
3.2 Global Metabolic Biomarker Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Metabolic Biomarker Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Metabolic Biomarker Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Metabolic Biomarker Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Metabolic Biomarker Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Metabolic Biomarker Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Metabolic Biomarker Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Metabolic Biomarker Testing Revenue Breakdown by Application (2018-2029)
4 Metabolic Biomarker Testing Competition Analysis by Players
4.1 Global Metabolic Biomarker Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Metabolic Biomarker Testing as of 2022)
4.3 Date of Key Players Enter into Metabolic Biomarker Testing Market
4.4 Global Top Players Metabolic Biomarker Testing Headquarters and Area Served
4.5 Key Players Metabolic Biomarker Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Metabolic Biomarker Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Agilent Technologies
5.1.1 Agilent Technologies Profile
5.1.2 Agilent Technologies Main Business
5.1.3 Agilent Technologies Metabolic Biomarker Testing Products, Services and Solutions
5.1.4 Agilent Technologies Metabolic Biomarker Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Agilent Technologies Recent Developments
5.2 Bio-Rad Laboratories
5.2.1 Bio-Rad Laboratories Profile
5.2.2 Bio-Rad Laboratories Main Business
5.2.3 Bio-Rad Laboratories Metabolic Biomarker Testing Products, Services and Solutions
5.2.4 Bio-Rad Laboratories Metabolic Biomarker Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Bio-Rad Laboratories Recent Developments
5.3 Bruker
5.3.1 Bruker Profile
5.3.2 Bruker Main Business
5.3.3 Bruker Metabolic Biomarker Testing Products, Services and Solutions
5.3.4 Bruker Metabolic Biomarker Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Danaher Recent Developments
5.4 Danaher
5.4.1 Danaher Profile
5.4.2 Danaher Main Business
5.4.3 Danaher Metabolic Biomarker Testing Products, Services and Solutions
5.4.4 Danaher Metabolic Biomarker Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Danaher Recent Developments
5.5 Waters Corporation
5.5.1 Waters Corporation Profile
5.5.2 Waters Corporation Main Business
5.5.3 Waters Corporation Metabolic Biomarker Testing Products, Services and Solutions
5.5.4 Waters Corporation Metabolic Biomarker Testing Revenue (US$ Million) & (2018-2023)
5.5.5 Waters Corporation Recent Developments
5.6 Thermo Fisher Scientific
5.6.1 Thermo Fisher Scientific Profile
5.6.2 Thermo Fisher Scientific Main Business
5.6.3 Thermo Fisher Scientific Metabolic Biomarker Testing Products, Services and Solutions
5.6.4 Thermo Fisher Scientific Metabolic Biomarker Testing Revenue (US$ Million) & (2018-2023)
5.6.5 Thermo Fisher Scientific Recent Developments
5.7 Biocrates Life Sciences
5.7.1 Biocrates Life Sciences Profile
5.7.2 Biocrates Life Sciences Main Business
5.7.3 Biocrates Life Sciences Metabolic Biomarker Testing Products, Services and Solutions
5.7.4 Biocrates Life Sciences Metabolic Biomarker Testing Revenue (US$ Million) & (2018-2023)
5.7.5 Biocrates Life Sciences Recent Developments
5.8 Human Metabolome Technologies
5.8.1 Human Metabolome Technologies Profile
5.8.2 Human Metabolome Technologies Main Business
5.8.3 Human Metabolome Technologies Metabolic Biomarker Testing Products, Services and Solutions
5.8.4 Human Metabolome Technologies Metabolic Biomarker Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Human Metabolome Technologies Recent Developments
6 North America
6.1 North America Metabolic Biomarker Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Metabolic Biomarker Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Metabolic Biomarker Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Metabolic Biomarker Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Metabolic Biomarker Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Metabolic Biomarker Testing Market Dynamics
11.1 Metabolic Biomarker Testing Industry Trends
11.2 Metabolic Biomarker Testing Market Drivers
11.3 Metabolic Biomarker Testing Market Challenges
11.4 Metabolic Biomarker Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
